Dane Andreeff - 16 Nov 2022 Form 4 Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Dane Andreeff
Issuer symbol: HSDT
Transactions as of: 16 Nov 2022
Net transactions value: +$39,288
Form type: 4
Filing time: 18 Nov 2022, 15:00:39 UTC
Previous filing: 14 Sep 2022
Next filing: 25 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HSDT	Common Stock	Purchase	$3,224	+10,000	+6.9%	$0.3224	154,819	16 Nov 2022	See footnote	F1
transaction	HSDT	Common Stock	Purchase	$18,195	+53,753	+35%	$0.3385	208,572	17 Nov 2022	See footnote	F1
transaction	HSDT	Common Stock	Purchase	$4,155	+12,275	+39%	$0.3385	43,920	17 Nov 2022	See footnote	F2
transaction	HSDT	Common Stock	Purchase	$12,682	+37,464	+16%	$0.3385	276,082	17 Nov 2022	See footnote	F3
transaction	HSDT	Common Stock	Purchase	$1,032	+3,049	+39%	$0.3385	10,930	17 Nov 2022	See footnote	F4
holding	HSDT	Common Stock						1,508	16 Nov 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F2	The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities owned by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F3	The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F4	The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.